|
|||||
|
|
Every 2-month belatacept maintenance therapy in kidney transplant recipients greater than 1-year posttransplant: A randomized,noninferiority trial |
|
| Authors: | Idelberto R. Badell Ronald F. Parsons Geeta Karadkhele Octav Cristea Sue Mead Shine Thomas Jennifer M. Robertson Grace S. Kim John J. Hanfelt Stephen O. Pastan Christian P. Larsen |
| Affiliation: | 1. Emory Transplant Center, Atlanta, Georgia, USA;2. Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA |
| Abstract: | |
| Keywords: | clinical research/practice clinical trial costimulation immunosuppressant – fusion proteins and monoclonal antibodies: belatacept immunosuppression/immune modulation immunosuppressive regimens – minimization/withdrawal kidney (allograft) function/dysfunction kidney transplantation/nephrology |